Comparing Levovist-Enhanced Pulse Inversion Harmonic Imaging and Ferumoxides-Enhanced MR Imaging of Hepatic Metastases
Chiara Del Frate1,2,
Chiara Zuiani1,
Viviana Londero1,
Giuseppe Como1,
Massimo Bazzocchi1,
Koenraad Mortele2 and
Pablo R. Ros2
1 Institute of Radiology, Udine University, Via Colugna 50, 33100 Udine,
Italy. 2 Department of Radiology, Brigham and Women's Hospital, 75 Francis St., Boston
MA 02115.
Fig. 1A.60-year-old man with colorectal carcinoma and metastatic
liver involvement suspected on sonography. Unenhanced sonogram of liver shows
solid and isoechoic focal lesion (arrow) with hypoechoic rim visible
in segment VII.
Fig. 1B.60-year-old man with colorectal carcinoma and metastatic
liver involvement suspected on sonography. Pulse inversion harmonic digital
sonogram shows first scan obtained 20 sec after Levovist ([SH U 508A]
Schering, Berlin, Germany) injection. Twenty seconds after Levovist
administration, increased conspicuity of lesion (arrow) related to
increased echogenicity of surrounding and still heterogeneous liver parenchyma
is seen.
Fig. 1C.60-year-old man with colorectal carcinoma and metastatic
liver involvement suspected on sonography. Pulse inversion harmonic digital
sonogram shows second scan obtained 100 sec after Levovist injection. At this
time, conspicuity between focal lesions and normal liver is optimal, and three
additional lesions (arrowheads) are now identified.
Fig. 1D.60-year-old man with colorectal carcinoma and metastatic
liver involvement suspected on sonography. Pulse inversion harmonic digital
sonogram shows third scan obtained 180 sec after Levovist injection. At this
time, there is still good contrast between normal liver parenchyma and focal
metastases, with little decrease in conspicuity. All lesions are still
detectable.
Fig. 1E.60-year-old man with colorectal carcinoma and metastatic
liver involvement suspected on sonography. Axial unenhanced turbo spin-echo
STIR T2-weighted MR image (TR/TE, 5100/90; inversion time, 120 msec;
matrix,196 x 256; number of excitations, 3; rectangular field of view,
6; field of view, 8; slice thickness, 8 mm; gap, 20%; acquisition time, 5 min
43 sec) shows multiple focal hyperintense liver lesions with ill-defined
borders.
Fig. 1F.60-year-old man with colorectal carcinoma and metastatic
liver involvement suspected on sonography. Axial ferumoxides-enhanced turbo
spin-echo STIR T2-weighted MR image shows that accumulation of ferumoxides
causes drop in signal intensity of normal parenchyma and increases contrast
between lesion and liver. After ferumoxides administration, all lesions
identified in unenhanced scan are confirmed, and four additional ones are
depicted (arrowheads). Moreover, lesions are better defined.
Fig. 2A.63-year-old woman with colon carcinoma. Unenhanced baseline
sonogram shows no definite lesions, even though liver parenchyma is not
perfectly homogeneous.
Fig. 2B.63-year-old woman with colon carcinoma. Pulse inversion
harmonic digital sonograms are serial scans obtained respectively at 20
(B), 100 (C), and 180 (D) sec after Levovist ([SH U 508A]
Schering, Berlin, Germany) injection. One liver lesion (arrow) is
visible in all scans, but is better seen in C and D, and appears
hypoechoic in comparison with surrounding normal liver parenchyma, which is
hyperechoic because of Levovist administration. Lesion was confirmed on MR
imaging (not shown) and proven to be metastasis after resection.
Fig. 2C.63-year-old woman with colon carcinoma. Pulse inversion
harmonic digital sonograms are serial scans obtained respectively at 20
(B), 100 (C), and 180 (D) sec after Levovist ([SH U 508A]
Schering, Berlin, Germany) injection. One liver lesion (arrow) is
visible in all scans, but is better seen in C and D, and appears
hypoechoic in comparison with surrounding normal liver parenchyma, which is
hyperechoic because of Levovist administration. Lesion was confirmed on MR
imaging (not shown) and proven to be metastasis after resection.
Fig. 2D.63-year-old woman with colon carcinoma. Pulse inversion
harmonic digital sonograms are serial scans obtained respectively at 20
(B), 100 (C), and 180 (D) sec after Levovist ([SH U 508A]
Schering, Berlin, Germany) injection. One liver lesion (arrow) is
visible in all scans, but is better seen in C and D, and appears
hypoechoic in comparison with surrounding normal liver parenchyma, which is
hyperechoic because of Levovist administration. Lesion was confirmed on MR
imaging (not shown) and proven to be metastasis after resection.
Fig. 3A.52-year-old man with colorectal carcinoma who was treated
with chemotherapy for liver lesions. Unenhanced sonogram of liver segment VII
shows solid hyperechoic metastasis with hypoechoic rim (arrow),
visible when compared with normal echogenicity of surrounding liver
parenchyma.
Fig. 3B.52-year-old man with colorectal carcinoma who was treated
with chemotherapy for liver lesions. Pulse inversion harmonic digital sonogram
is second scan obtained at 100 sec after Levovist ([SH U 508A] Schering,
Berlin, Germany) injection, after which, in comparison with unenhanced scan
(A), echogenicity of normal liver parenchyma is increased. As a
consequence, conspicuity of focal lesion (arrow) described in
A decreased.
Fig. 3C.52-year-old man with colorectal carcinoma who was treated
with chemotherapy for liver lesions. Unenhanced sonogram obtained in segment
VII shows that heterogeneity of parenchyma seems to be present in subcapsular
area, but isolated lesion (arrow) is not identified.
Fig. 3D.52-year-old man with colorectal carcinoma who was treated
with chemotherapy for liver lesions. Pulse inversion harmonic digital sonogram
is second scan obtained at 100 sec after Levovist injection. In same area as
in C, hypoechoic lesion (arrow) is now visible. Vessel
simulating hyperechoic lesion with hypoechoic rim is visible
(arrowhead); this appearance can mimic focal lesion when there is not
careful comparison between unenhanced and contrastenhanced images.
Fig. 4.Graph compares grade of lesion conspicuity (excellent [1],
good [2], moderate [3], and poor [4]) obtained with different scans
(unenhanced and at 20, 100, and 180 sec after contrast media administration).
Graph shows that, in our experience, scan at 100 sec after Levovist ([SH U
508A] Schering, Berlin, Germany) injection shows best performance, followed by
scan at 180 sec.